SLP vs WSBF
SLP: Simulations Plus provides AI-enabled modeling and simulation software and services to help biopharmaceutical companies accelerate drug development and improve clinical trial outcomes. WSBF: A dual-segment financial institution combining a regional Wisconsin community bank with a national residential mortgage origination platform.
Side-by-side fundamentals
| Metric | SLP | WSBF | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $18.50 | $19.55 | |
| Market cap | $374M | $351M | |
| P/E as of 2026-10-30 | 46.25 | 11.30 | WSBF lower |
| Net margin FY2025, SEC XBRL | -81.7% | n/a | |
| Gross margin FY2025, SEC XBRL | +58.4% | n/a | |
| Operating margin FY2025, SEC XBRL | -89.3% | n/a | |
| ROE FY2025, SEC XBRL | -51.9% | +7.6% | WSBF higher |
| ROA FY2025, SEC XBRL | -49.1% | +1.2% | WSBF higher |
| Debt / equity | 0.00 | 1.17 | SLP lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +13.1% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +13.7% | n/a | |
| Dividend yield as of 2026-09-02 | n/a | 3.48% | |
| Dividend streak (yrs) SEC XBRL | 6 | 2 | SLP higher |
| Beta as of 2026-09-02 | 0.82 | 0.52 | |
| 1-year return as of 2026-10-30 close | +7.8% | +27.9% | WSBF higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.